Researchers are exploring various immunological approaches to address recurrent early pregnancy loss, including the potential role of low-dose interleukin-2. Other studies are investigating the involvement of different immune cells and factors, such as regulatory t cells, natural killer cells, and inflammasomes, in pregnancy complications. The effectiveness of different treatments, including glucocorticoids and immunosuppressive therapy, in improving pregnancy outcomes is also being examined.